Vincerx Pharma Inc
NASDAQ:VINC
Cash Flow Statement
Cash Flow Statement
Vincerx Pharma Inc
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(1)
|
(17)
|
(23)
|
(25)
|
(49)
|
(39)
|
(49)
|
(66)
|
(58)
|
(65)
|
(63)
|
(56)
|
(49)
|
(40)
|
(38)
|
(29)
|
(27)
|
(30)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
4
|
9
|
16
|
22
|
23
|
24
|
21
|
17
|
12
|
8
|
6
|
5
|
4
|
3
|
3
|
3
|
3
|
|
| Other Non-Cash Items |
(0)
|
15
|
17
|
8
|
21
|
0
|
(1)
|
10
|
0
|
7
|
7
|
6
|
5
|
4
|
9
|
4
|
4
|
4
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(1)
|
1
|
3
|
4
|
6
|
5
|
3
|
1
|
(1)
|
(2)
|
(4)
|
(2)
|
(4)
|
(6)
|
(3)
|
(5)
|
(0)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(2)
-694%
|
(6)
-154%
|
(14)
-140%
|
(24)
-73%
|
(33)
-39%
|
(45)
-35%
|
(53)
-17%
|
(57)
-9%
|
(60)
-4%
|
(58)
+3%
|
(54)
+6%
|
(46)
+15%
|
(40)
+13%
|
(35)
+13%
|
(28)
+20%
|
(28)
+1%
|
(26)
+7%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
(5)
|
(5)
|
(5)
|
(5)
|
0
|
0
|
(20)
|
(41)
|
(35)
|
(20)
|
15
|
42
|
36
|
12
|
(1)
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
(5)
N/A
|
(5)
-5%
|
(5)
0%
|
(5)
0%
|
(0)
+95%
|
(0)
+88%
|
(20)
-67 243%
|
(41)
-101%
|
(35)
+15%
|
(20)
+43%
|
15
N/A
|
42
+170%
|
36
-14%
|
12
-65%
|
(1)
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
41
|
88
|
88
|
0
|
48
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
17
|
18
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
64
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
64
N/A
|
0
N/A
|
105
N/A
|
152
+45%
|
88
-42%
|
0
N/A
|
48
N/A
|
1
-99%
|
0
-47%
|
0
+1%
|
0
-53%
|
0
N/A
|
0
-15%
|
0
+2%
|
17
+14 577%
|
17
N/A
|
18
+6%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Net Change in Cash |
1
N/A
|
62
+11 390%
|
53
-14%
|
86
+61%
|
123
+44%
|
50
-60%
|
43
-13%
|
(5)
N/A
|
(77)
-1 536%
|
(100)
-30%
|
(92)
+8%
|
(74)
+19%
|
(31)
+59%
|
1
N/A
|
1
-44%
|
1
+99%
|
(12)
N/A
|
(8)
+36%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(2)
-694%
|
(6)
-154%
|
(14)
-144%
|
(24)
-72%
|
(34)
-38%
|
(45)
-34%
|
(53)
-17%
|
(57)
-9%
|
(60)
-4%
|
(58)
+3%
|
(54)
+6%
|
(46)
+15%
|
(40)
+13%
|
(35)
+13%
|
(28)
+20%
|
(28)
+1%
|
(26)
+7%
|
|